GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC10981 structure
    GC10981Disodium (R)-2-Hydroxyglutarate
    CAS: 103404-90-6
    Purity: >95.00%

    Le disodium (R)-2-hydroxyglutarate (Disodium (R)-2-hydroxyglutarate) est le principal métabolite qui s'accumule dans la maladie neurométabolique D-2-hydroxyglutaric acidurie.

  • GC11032 structure
    GC11032Cl-Amidine (trifluoroacetate salt)
    CAS: 1043444-18-3
    Purity: >97.00%

    Cl-Amidine (trifluoroacetate salt) est un inhibiteur de multi-cibles de déaminase de la peptidylarginine (PAD) avec le groupe fonctionnel RC(NR)NR2 qui inhibe inhibits PAD1 (IC 50 =0.8μM), PAD3 (IC 50 =6.2μM), et PAD4 (IC 50 =5.9μM) avec la demi-vie de 15 minutes.

  • GC11034 structure
    GC11034TP-808
    CAS: 852821-06-8
    Purity: >98%

    intermediate for the synthesis of diverse tetracycline antibiotics

  • GC11163 structure
    GC11163L-NMMA (citrate)
    Purity: >98.00%

    relatively non-selective inhibitor of all NOS isoforms

  • GC11168 structure
    GC11168Motolimod (VTX-2337)
    CAS: 926927-61-9
    Purity: >98.00%

    Motolimod (VTX-2337) (VTX-2337; VTX-378) est un agoniste sélectif du récepteur de type Toll 8 (TLR8), avec une EC50 d'environ 100 nM.

  • GC11170 structure
    GC11170Choline Fenofibrate
    CAS: 856676-23-8
    Purity: >98.00%
  • GC11173 structure
    GC111731,3-PBIT (dihydrobromide)
    CAS: 200716-66-1
    Purity: >98%

    potent inhibitor of iNOS

  • GC11294 structure
    GC11294TAK-242 S enantiomer
    CAS: 243984-10-3
    Purity: >98.00%

    TLR 4 signaling inhibitor

  • GC11302 structure
    GC11302Hinokitiol
    CAS: 499-44-5
    Purity: >98.00%

    Hinokitiol est une molécule de type tropolone naturelle extraite de Formosan cypress avec des propriétés antibactériennes et anticancéreuses.

  • GC11323 structure
    GC11323α-Guanidinoglutaric Acid
    CAS: 73477-53-9
    Purity: >98%

    linear mixed-type inhibitor of nNOS

  • GC11328 structure
    GC11328Cyclosporine
    CAS: 59865-13-3
    Purity: >99.50%

    Cyclosporine (cyclosporin A), un agent immunosuppressif, inhibe l'activité de la phosphatase de la calcineurine, sa valeur d'IC50 est 5 nM.

  • GC11443 structure
    GC11443Allylthiourea
    CAS: 109-57-9
    Purity: >98.00%

    L'allylthiourée est un inhibiteur métabolique qui inhibe sélectivement l'oxydation de l'ammoniac.

  • GC11461 structure
    GC11461CU CPT 4a
    CAS: 1279713-77-7
    Purity: >98.00%

    CU CPT 4a est un inhibiteur puissant du récepteur de type Toll 3 (TLR3), avec une valeur d' IC 50 de 3.44μM.

  • GC11508 structure
    GC11508IKK-2 inhibitor VIII
    CAS: 406209-26-5
    Purity: >99.50%
  • GC11513 structure
    GC11513Zofenopril calcium
    CAS: 81938-43-4
    Purity: >99.50%

    Le zofénopril calcique (SQ26991) est un antioxydant qui agit comme un inhibiteur de l'enzyme de conversion de l'angiotensine.

  • GC11609 structure
    GC11609Nω-Propyl-L-arginine hydrochloride
    CAS: 137361-05-8
    Purity: >98%

    neuronal nitric oxide synthase (nNOS) inhibitor

  • GC11660 structure
    GC11660Nitisinone
    CAS: 104206-65-7
    Purity: >99.50%

    La nitisinone est un inhibiteur de la 4-hydroxyphénylpyruvate dioxygénase (4-HPPD) actif par voie orale, compétitif et réversible avec une IC50 de 173 nM.

  • GC11664 structure
    GC11664YM 90709
    CAS: 163769-88-8
    Purity: >99.50%

    YM 90709 est un nouvel inhibiteur de l'IL-5 qui bloque sélectivement la liaison de l'IL-5 au récepteur de l'IL-5 (IL-5R).

  • GC11670 structure
    GC11670Pranoprofen
    CAS: 52549-17-4
    Purity: >98.00%

    Le pranoprofène est un agent anti-inflammatoire non stéroÏdien (AINS) pour la recherche de kératites ou d'autres maladies ophtalmologiques.

  • GC11698 structure
    GC11698Valaciclovir HCl
    CAS: 124832-27-5
    Purity: >98%

    Le chlorhydrate de valaciclovir (chlorhydrate de valaciclovir) est un médicament antiviral actif par voie orale contre l'herpès simplex, le zona et l'herpès B.

  • GC11702 structure
    GC11702DL-Carnitine HCl
    CAS: 461-05-2
    Purity: >98.00%

    DL-Carnitine HCl existe en deux isomères, connus sous le nom de D et L.

  • GC11707 structure
    GC11707L-Ascorbyl 6-palmitate
    CAS: 137-66-6
    Purity: >99.00%

    Le 6-palmitate de L-ascorbyle est un ester formé à partir d'acide ascorbique et d'acide palmitique créant une vitamine C, il est également utilisé comme additif alimentaire antioxydant.

  • GC11736 structure
    GC11736NF-κB Activation Inhibitor III
    CAS: 380623-76-7
    Purity: >98%

    NF-κB Activation Inhibitor III est un puissant inhibiteur de NF-kB qui cible en aval de l'activation de MAPK p38. NF-κB Activation Inhibitor III inhibe la régulation À la hausse induite par TNF-α MMP-9. NF-κB Activation Inhibitor III peut être utilisé pour la recherche de chimiothérapies ciblant l'invasion tumorale et les métastases médiées par le TNF-α.

  • GC11743 structure
    GC11743MF63
    CAS: 892549-43-8
    Purity: >99.00%

    A potent, selective, and orally active mPGES-1 inhibitor